Tag: controlled_substances_act

DEA Temporarily Schedules 7-OH and Related Substances as Schedule I

1 Jul 2026 4:27 p.m.

The DEA will temporarily schedule 7-hydroxymitagynine (7-OH) and three related synthetic substances as Schedule I controlled substances. This action, supported by HHS, targets dangerous opioid-like products to protect public safety and combat the opioid epidemic.

Politics and Government Health Law Enforcement Federal Government Social Issues Legal DEA 7-hydroxymitagynine Controlled Substances Act Opioid Epidemic Public Safety Drug Enforcement HHS
DEA to Begin Formal Hearings on Marijuana Rescheduling

25 Jun 2026 10:03 a.m.

The DEA will hold formal hearings from June 29 to July 15, 2026, on the proposed rescheduling of marijuana from Schedule I to Schedule III of the Controlled Substances Act, a move supported by HHS and DOJ.

Politics and Government Health Law Enforcement Media General Politics Federal Government Legal Social Issues Medical Science Marijuana Drug Rescheduling DEA Controlled Substances Act Arlington, Virginia Government Hearings Public Policy